Biotech / Medical
Neptune Technologies & Bioressources Inc. - NTB.V
An SI Board Since July 2011
Posts SubjectMarks Bans Symbol
441 14 0 NEPT
Emcee:  Sultan Type:  Unmoderated
Neptune Wellness Solutions researches, develops and commercializes proprietary bioactive
ingredients and products with the goal of superior added-value and clinically proven health benefits. The
Company extracts a range of bioactive ingredients such as novel proprietary omega-3 phospholipids from
abundant yet underexploited marine biomass including Krill, a cold deep water zooplankton. Neptune’s
first commercially available product is Neptune Krill Oil (NKO®), which represents marine based omega-3
phospholipids with potential in cardiovascular, cognitive and anti-inflammatory disorders. Neptune is pursuing
market opportunities in the nutraceutical market including dietary supplements and functional foods. The
Company is also pursuing opportunities in the pharmaceutical market through its pharmaceutical subsidiaries,Acasti and NeuroBioPharm (including medical food, over-the-counter and prescription drug applications).

NOTE: Neptune trades on Toronto.. For Canadian & US quote, enter NEPT

Acasti Pharma Inc. is 35% owned by Neptune.. For Canadian & US quote, enter ACST
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
441Three stocks benefiting from the cannabis boom, even though they don't grow Sultan-4 minutes ago
440Cannabis Outlook 2018: Pressure Effects from Canadian Legalization INN takes a Sultan1an hour ago
439Neptune takes MaxSimil delivery technology into sports channel12-Dec-2017 By HanSultan-an hour ago
438Message 31386087The Ox1an hour ago
437Echelon hikes target to $5.25 Globe says Neptune Tech's move on weed calleSultan2Monday
436Strength Sensei Nutraceuticals and Charles R. Poliquin launch MaxSimil® fiSultan-Monday
435NEPT is doing well on both TSX and Nasdaq.. Up 16% + on nice volume.. No newsSultan-last Friday
434Anyone Who Resists the Rise of Legal Cannabis Is Among Dumbest on Wall Street Sultan-December 3
433Neptune licenses bioavailability enhancement technology for CBDs 29-Nov-2017 BySultan-November 30
432Neptune Receives Nasdaq Notification Confirming that it has Regained Compliance Sultan-November 30
431Neptune Wellness Solutions downgraded to “HOLD” at Echelon Wealth cantechletter.Sultan-November 28
430Slides from today's Business Update Presentation neptunecorp.comSultan1November 28
429November 27, 2017 08:00 ET Neptune Extends Global MaxSimil® Licence To CanSultan-November 27
428Acasti - Company Overview - filed pursuant to Rule 433 sec.govSultan-November 25
427Acasti F-1/A sec.govSultan-November 24
426Acasti Pharma Clarifies Term of Proposed Strategic Partnership with Leading ChinSultan-November 22
425CaPre acastipharma.comSultan-November 20
424Acasti Pharma Announces Development and Commercialization Discussions ProgressinSultan-November 20
423Q2 2018 Results - Earnings Call Transcript seekingalpha.comSultan-November 15
422Neptune Announces Second Quarter Results Earning CC Slides Sultan-November 14
421Neptune to Hold Conference Call to Discuss Second Quarter Results for the InteriSultan-November 13
420Acasti Pharma Announces Dariush Mozaffarian, M.D., Dr.P.H. Principal InvestigatoSultan-November 7
419Oils and more: Neptune explores new frontiers in cannabis space nutritioninsighSultan-November 7
418Neptune appoints Eric Krudener Neptune is pleased to announce the appointment oSultan-November 6
417Amid the ‘green rush,’ suits are taking over Canada’s cannabis industry The burSultan-November 6
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
Copyright © 1995-2017 Knight Sac Media. All rights reserved.Stock quotes are delayed at least 15 minutes - See Terms of Use.